We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stay Ahead of the Game With DexCom (DXCM) Q3 Earnings: Wall Street's Insights on Key Metrics
Read MoreHide Full Article
In its upcoming report, DexCom (DXCM - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.43 per share, reflecting a decline of 14% compared to the same period last year. Revenues are forecasted to be $991.55 million, representing a year-over-year increase of 1.7%.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Bearing this in mind, let's now explore the average estimates of specific DexCom metrics that are commonly monitored and projected by Wall Street analysts.
Analysts predict that the 'Revenue- Hardware' will reach $49.44 million. The estimate points to a change of -51.2% from the year-ago quarter.
Based on the collective assessment of analysts, 'Revenue- Sensor and other' should arrive at $941.35 million. The estimate points to a change of +7.7% from the year-ago quarter.
Analysts forecast 'Revenue- United States' to reach $719.01 million. The estimate points to a change of +0.8% from the year-ago quarter.
The consensus among analysts is that 'Revenue- International' will reach $265.16 million. The estimate points to a change of +1.4% from the year-ago quarter.
Shares of DexCom have experienced a change of +2.8% in the past month compared to the +4.5% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), DXCM is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Stay Ahead of the Game With DexCom (DXCM) Q3 Earnings: Wall Street's Insights on Key Metrics
In its upcoming report, DexCom (DXCM - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.43 per share, reflecting a decline of 14% compared to the same period last year. Revenues are forecasted to be $991.55 million, representing a year-over-year increase of 1.7%.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Bearing this in mind, let's now explore the average estimates of specific DexCom metrics that are commonly monitored and projected by Wall Street analysts.
Analysts predict that the 'Revenue- Hardware' will reach $49.44 million. The estimate points to a change of -51.2% from the year-ago quarter.
Based on the collective assessment of analysts, 'Revenue- Sensor and other' should arrive at $941.35 million. The estimate points to a change of +7.7% from the year-ago quarter.
Analysts forecast 'Revenue- United States' to reach $719.01 million. The estimate points to a change of +0.8% from the year-ago quarter.
The consensus among analysts is that 'Revenue- International' will reach $265.16 million. The estimate points to a change of +1.4% from the year-ago quarter.
View all Key Company Metrics for DexCom here>>>
Shares of DexCom have experienced a change of +2.8% in the past month compared to the +4.5% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), DXCM is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>